Open the mobile version, with barcode scanning
Class II Ongoing

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

Why: cGMP deviations.

Company
Wells Pharma of Houston LLC
Houston, TX, United States
Reported
May 6, 2026
Recall started
Apr 1, 2026
Where sold
U.S. Nationwide.
Amount
50 syringes
Full product description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Lots / codes affected
Lot 020226202150202, Exp Date 05/05/2026.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.